Developer docs
API playgroundTry for free, no card

Search company profiles

Coyote Ventures

Full company profile

uuid000075w

Namestring
Coyote Ventures
Legal namestring
Coyote Ventures
Websiteurl
coyote.ventures
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Coyote Ventures is a Delaware-registered venture capital firm headquartered in San Francisco, founded in 2021 by Jessica Karr (formerly the 12th employee at Impossible Foods). The firm operates as a pre-seed and seed-stage investor focused on health equity and women's health, deploying capital into tech-enabled solutions that address access gaps for women and historically marginalized communities. Its stated thesis is organized around five pillars: Human Health & Lifespan, Social & Structural Health, Whole-Person Health, Systems & Infrastructure, and Science & Frontier Technology. As of the 2025 Impact Report, the portfolio comprises 19 companies spanning maternal health (Millie, Hey Malama), sexual wellness (Maude, Flex), menopause (Wile), oncology diagnostics (Gabbi, Hera Biotech), fertility financing (Sunfish), bereavement (Betterleave), caregiving (Magnolia), SDOH data (Alvee), payer analytics (Lilac Software), care decision support (Koda Health), parental leave benefits (ParentOleave), culturally competent nutrition (Pom Health), financial wellness for care workers (The Beans), and parent community (Auggie).

The firm does not develop proprietary technology products; its intellectual property is its investment thesis framework, its structured impact measurement methodology, and its network of healthcare executives, doctors, scientists, payers, and policymakers. Coyote raises capital from institutional Limited Partners (with Bank of America as the largest LP in Fund I, alongside The Case for Her and Tripple Family Office) and generates revenue through the standard VC model of management fees (typically ~2% of committed capital) and carried interest (typically ~20% of profits above the hurdle) on portfolio exits. Distribution and sourcing channels include direct outreach, warm introductions, participation in Y Combinator and Vive Collective, and biannual Health Equity Innovators Summit events. The firm is led by General Partner Jessica Karr, supported by a three-person Investment Committee and seven Venture Partners drawn from Adobe, Google, Kaiser Permanente, Mercer, UnitedHealthcare/Optum, Delfina, and Oak Street Health.

Short descriptiontext

Coyote Ventures is a San Francisco-based pre-seed and seed venture capital firm founded in 2021 by Jessica Karr that invests in tech-enabled health equity and women's health startups, managing a portfolio of 19 companies with Bank of America as its largest Fund I institutional LP.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
venture capital investing, health equity investing, pre-seed funding, seed-stage investing, women's health ventures
Industry3 codes
PRIMARYFSANAAAA
Early-Stage Venture Capital (Pre-Seed/Seed)
SECONDARYFSANAJAI
Healthcare Access & Life Sciences Impact Funds
Financial & Insurance/Private Equity & Venture Capital/Impact / ESG & Sustainable Investment Funds
SECONDARYBPAGALAA
Impact Investing & Social Finance (Funds, CDFIs, Microfinance)
Business & Public Services/Nonprofit, NGO & Social Services/Social Enterprises & Impact Organizations
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Portfolio Management and Investment Advice52394
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital / Healthcare Investment
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Fund Management
TypeLicensing Royalties
Description

Venture capital fund generating returns through management fees (typically 2% of committed capital) and carried interest (typically 20% of profits above the hurdle rate). Returns realized through portfolio company exits via acquisition, IPO, or secondary sales.

coyote.ventures
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Coyote Ventures manages a pre-seed and seed-stage venture capital fund (Fund I) that invests in tech-enabled health equity companies serving women and historically marginalized populations, while providing portfolio founders with capital, strategic guidance, network access, and biannual Health Equity Innovators Summit programming. The firm earns returns through standard venture fund economics of management fees and carried interest, sourced from a portfolio of 19 companies spanning maternal health, sexual wellness, breast cancer risk, endometriosis, bereavement, fertility financing, caregiver support, SDOH data, payer analytics, and financial wellness for care workers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 95% of portfolio companies are female-led with 57% of co-founders identifying as BIPOC
+2 more records
Product overview1 text field

Coyote Ventures is a pre-seed and seed-stage venture capital firm founded in 2021 that invests in tech-enabled solutions driving healthcare access for overlooked populations, with a focus on women and historically marginalized communities. The firm's portfolio comprises 19 companies spanning multiple health equity verticals including maternal health (Hey Malama, Millie), sexual wellness (Maude), menopause and perimenopause (Wile), breast cancer risk assessment (Gabbi), endometriosis diagnostics (Hera Biotech), period care (Flex Company), bereavement support (Betterleave), caregiver support (Magnolia), fertility financing (Sunfish), SDOH data management (Alvee), payer analytics (Lilac Software), healthcare decision support (Koda Health), parental leave benefits (ParentOleave), nutrition care (Pom Health), financial wellness for care workers (The Beans), and general parenting (Auggie). The fund does not offer its own product or service; its investment activity and portfolio companies constitute its business.

Product and service1 record
1Coyote Ventures Fund I
CategoryVenture Capital Fund
Description

Pre-seed and seed-stage venture capital fund that invests in tech-enabled health equity companies serving women and historically marginalized populations, with returns generated through management fees and carried interest on portfolio exits. The fund provides portfolio companies with capital, strategic guidance, network access to healthcare executives and payers, and biannual Health Equity Innovators Summit programming.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierMinorTypeGTM or Marketing Partner
Description

Group of female general partners through which Coyote was introduced to portfolio company Betterleave.

2Healthequityinnovators.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dedicated platform for the Health Equity Innovators Summit, a core community-building and networking initiative for the health equity ecosystem.

coyote.ventures
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers20 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment16 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Coyote Ventures

Venture Capital / Healthcare Investmentcoyote.ventures

Coyote Ventures is a San Francisco-based pre-seed and seed venture capital firm founded in 2021 by Jessica Karr that invests in tech-enabled health equity and women's health startups, managing a portfolio of 19 companies with Bank of America as its largest Fund I institutional LP.

What Coyote Ventures does

Coyote Ventures is a Delaware-registered venture capital firm headquartered in San Francisco, founded in 2021 by Jessica Karr (formerly the 12th employee at Impossible Foods). The firm operates as a pre-seed and seed-stage investor focused on health equity and women's health, deploying capital into tech-enabled solutions that address access gaps for women and historically marginalized communities. Its stated thesis is organized around five pillars: Human Health & Lifespan, Social & Structural Health, Whole-Person Health, Systems & Infrastructure, and Science & Frontier Technology. As of the 2025 Impact Report, the portfolio comprises 19 companies spanning maternal health (Millie, Hey Malama), sexual wellness (Maude, Flex), menopause (Wile), oncology diagnostics (Gabbi, Hera Biotech), fertility financing (Sunfish), bereavement (Betterleave), caregiving (Magnolia), SDOH data (Alvee), payer analytics (Lilac Software), care decision support (Koda Health), parental leave benefits (ParentOleave), culturally competent nutrition (Pom Health), financial wellness for care workers (The Beans), and parent community (Auggie).

The firm does not develop proprietary technology products; its intellectual property is its investment thesis framework, its structured impact measurement methodology, and its network of healthcare executives, doctors, scientists, payers, and policymakers. Coyote raises capital from institutional Limited Partners (with Bank of America as the largest LP in Fund I, alongside The Case for Her and Tripple Family Office) and generates revenue through the standard VC model of management fees (typically ~2% of committed capital) and carried interest (typically ~20% of profits above the hurdle) on portfolio exits. Distribution and sourcing channels include direct outreach, warm introductions, participation in Y Combinator and Vive Collective, and biannual Health Equity Innovators Summit events. The firm is led by General Partner Jessica Karr, supported by a three-person Investment Committee and seven Venture Partners drawn from Adobe, Google, Kaiser Permanente, Mercer, UnitedHealthcare/Optum, Delfina, and Oak Street Health.

Coyote Ventures firmographics

Firmographics
Name
Coyote Ventures
Legal name
Coyote Ventures
Website
https://coyote.ventures
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Coyote Ventures is a San Francisco-based pre-seed and seed venture capital firm founded in 2021 by Jessica Karr that invests in tech-enabled health equity and women's health startups, managing a portfolio of 19 companies with Bank of America as its largest Fund I institutional LP.
Ownership category
akta.pro rank

Coyote Ventures industry classification

Industry
Product category
Venture Capital / Healthcare Investment
NAICS
Portfolio Management and Investment Advice (523940), Portfolio Management and Investment Advice (52394)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAA
Early-Stage Venture Capital (Pre-Seed/Seed)
SECONDARYFSANAJAI
Healthcare Access & Life Sciences Impact Funds
Financial & Insurance/Private Equity & Venture Capital/Impact / ESG & Sustainable Investment Funds
SECONDARYBPAGALAA
Impact Investing & Social Finance (Funds, CDFIs, Microfinance)
Business & Public Services/Nonprofit, NGO & Social Services/Social Enterprises & Impact Organizations

Keywords

  • Venture capital investing
  • Health equity investing
  • Pre-seed funding
  • Seed-stage investing
  • Women's health ventures

Where Coyote Ventures is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Markets served

Coyote Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Fund Management: Venture capital fund generating returns through management fees (typically 2% of committed capital) and carried interest (typically 20% of profits above the hurdle rate). Returns realized through portfolio company exits via acquisition, IPO, or secondary sales.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Coyote Ventures product offering

Product offering

Core offering

Coyote Ventures manages a pre-seed and seed-stage venture capital fund (Fund I) that invests in tech-enabled health equity companies serving women and historically marginalized populations, while providing portfolio founders with capital, strategic guidance, network access, and biannual Health Equity Innovators Summit programming. The firm earns returns through standard venture fund economics of management fees and carried interest, sourced from a portfolio of 19 companies spanning maternal health, sexual wellness, breast cancer risk, endometriosis, bereavement, fertility financing, caregiver support, SDOH data, payer analytics, and financial wellness for care workers.

Product overview

Coyote Ventures is a pre-seed and seed-stage venture capital firm founded in 2021 that invests in tech-enabled solutions driving healthcare access for overlooked populations, with a focus on women and historically marginalized communities. The firm's portfolio comprises 19 companies spanning multiple health equity verticals including maternal health (Hey Malama, Millie), sexual wellness (Maude), menopause and perimenopause (Wile), breast cancer risk assessment (Gabbi), endometriosis diagnostics (Hera Biotech), period care (Flex Company), bereavement support (Betterleave), caregiver support (Magnolia), fertility financing (Sunfish), SDOH data management (Alvee), payer analytics (Lilac Software), healthcare decision support (Koda Health), parental leave benefits (ParentOleave), nutrition care (Pom Health), financial wellness for care workers (The Beans), and general parenting (Auggie). The fund does not offer its own product or service; its investment activity and portfolio companies constitute its business.

Differentiator

Problem solved

Functional benefit

Products and services

  • Coyote Ventures Fund I Pre-seed and seed-stage venture capital fund that invests in tech-enabled health equity companies serving women and historically marginalized populations, with returns generated through management fees and carried interest on portfolio exits. The fund provides portfolio companies with capital, strategic guidance, network access to healthcare executives and payers, and biannual Health Equity Innovators Summit programming.

Quantifiable outcome

  • 95% of portfolio companies are female-led with 57% of co-founders identifying as BIPOC
  • +2 more outcomes

Companies that use Coyote Ventures

Customer profile

Named customers20 records

Segments2 records

Ideal customer profiles2 records

Coyote Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Coyote Ventures partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered minor and core.

  • Transact GlobalminorGTM or Marketing PartnerGroup of female general partners through which Coyote was introduced to portfolio company Betterleave.
  • Healthequityinnovators.comcoreStrategic or Co-development PartnerDedicated platform for the Health Equity Innovators Summit, a core community-building and networking initiative for the health equity ecosystem.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Coyote Ventures competitors and assessment

Company assessment

Market position

Strengths4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Coyote Ventures social profiles

Digital presence

Coyote Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Coyote Ventures leadership team

Management profile

Number of profiles

Profiles12 records

Coyote Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Coyote Ventures M&A and investment

M&A and investment

M&A

Investments16 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Coyote Ventures

What does Coyote Ventures do?

Coyote Ventures manages a pre-seed and seed-stage venture capital fund (Fund I) that invests in tech-enabled health equity companies serving women and historically marginalized populations, while providing portfolio founders with capital, strategic guidance, network access, and biannual Health Equity Innovators Summit programming. The firm earns returns through standard venture fund economics of management fees and carried interest, sourced from a portfolio of 19 companies spanning maternal health, sexual wellness, breast cancer risk, endometriosis, bereavement, fertility financing, caregiver support, SDOH data, payer analytics, and financial wellness for care workers.

Is Coyote Ventures a public or private company?

Coyote Ventures is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Coyote Ventures founded?

Coyote Ventures was founded in 2021. It employs 11 to 50 people.

Where is Coyote Ventures based?

Coyote Ventures is headquartered in San Francisco, United States, in the North America region.

How does Coyote Ventures make money?

One revenue line is on record: fund Management.

Does Coyote Ventures have an API?

No public API is recorded for Coyote Ventures.

What industry is Coyote Ventures in?

Coyote Ventures's product category is Venture Capital / Healthcare Investment. Its primary akta.pro industry code is FSANAAAA, Early-Stage Venture Capital (Pre-Seed/Seed), with a secondary code of FSANAJAI, Healthcare Access & Life Sciences Impact Funds. Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The SaaS NewsKiara Health Raises Undisclosed Pre-seedKiara Health has secured an undisclosed pre-seed funding round led by Coyote Ventures to advance its AI-powered personalized fertility intelligence platform. The company plans to utilize the capital to expand its digital engine across various reproductive lifestages, including IVF preparation, pregnancy risk prediction, and menopause care.FierceHealthcareNew Medicaid-focused doula provider Malama launches with $9.2MMalama Health, a doula-led maternal care provider focused on Medicaid patients, has closed a $9.2 million seed round led by Acumen America with participation from Wisdom Ventures, Capital F, Coyote Ventures, and angel investors, along with a $2.3 million NIH grant and over $1 million in California state funding. The company will use the capital to expand to additional Medicaid markets, grow its doula workforce, and deepen community health center partnerships, with plans to move toward deeper value-based care as it accumulates more outcomes data. Patient-reported data from over 2,300 patients demonstrates significant clinical impact, including a 45% decrease in preterm birth rates, 19% decrease in NICU admissions, and 40% difference in postpartum diabetes outcomes compared to standard care.CoyoteHormone Intelligence: The New Frontier of Biomarker Tracking — Coyote VenturesCoyote Ventures published an industry analysis mapping the emerging hormone monitoring ecosystem, covering technologies transitioning from clinic-based blood draws to continuous at-home and wearable monitoring across fertility, wellness, stress, and metabolic health applications. The article profiles multiple early-stage companies—including Level Zero Health (raised $6.9M pre-seed), Persperity (raised $1M pre-seed), Impli (partnered with Bayer), Mira, Oova, Corti, and Lume Health—alongside established players like Oura and Natural Cycles. Key challenges identified include clinical validation requirements, regulatory hurdles for FDA clearance, accuracy gaps compared to gold-standard blood tests, cost barriers limiting insurance coverage, and the need for extensive trials before mainstream clinical adoption.CoyoteWhy We Invested: Auggie — Coyote VenturesAuggie, an AI-powered platform for parents, raised a seed round with Coyote Ventures and others. The platform scrapes community conversations for product recommendations, and a survey of 500 moms found 100% of first-time parents relied on friends for authentic advice. Auggie plans to expand with AI registries and shoppable video reviews.ForbesVC Identifies Market Opportunities In The Women’s Health And Wellness SpaceThe article reports on venture capital investments in the women’s health and wellness sector, emphasizing the growth and investment opportunities driven by female investors and founders. Jessica Karr, of Coyote Ventures, highlights the sector's under-investment and discusses strategies to attract more funding, especially from female accredited investors.ForbesVC Identifies Market Opportunities In The Women’s Health And Wellness SpaceCoyote Ventures, led by Jessica Karr, invests in women's health and wellness, noting the sector represents about 2% of health investment. Female founder funding declined in 2022, with dollars and deals dropping 22% and 11% respectively. Karr suggests raising accredited investor limits to $50 million and 499 investors to improve access.Business Wire BlogVC Fund Coyote Ventures Raises from Bank of America for Inaugural FundCoyote Ventures, a venture firm for women's health startups, announced an LP investment from Bank of America. The firm has invested in six startups, and Bank of America is the largest institutional investor in its inaugural fund. The investment aims to address the underserved market of women's health solutions.The Founder InstituteHow to Invest in Pre-Seed Startups, with Coyote Ventures, Startup Haven Ventures & Untapped Capital (video)Coyote Ventures, Startup Haven Ventures, and Untapped Capital participated in an investor roundtable hosted by the Leading Institute to discuss strategies for investing in pre-seed startups. The event featured general partners from these firms sharing best practices on sourcing early-stage opportunities and pooling resources to support entrepreneurs across various sectors and regions.